Anemia in cystic fibrosis: Incidence, mechanisms, and association with pulmonary function and vitamin deficiency

Nutrition in Clinical Practice

Volumn 23, Issue 5, 2008, Pages 557-563

  Von Drygalski, Annette ^a,d   Biller, Julie ^a,b,c  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Anemia; Avitaminosis; Cystic fibrosis; Hemoglobins; Inflammation; Iron deficiency; Respiratory function tests

Indexed keywords

CREATININE; IRON; HEMOGLOBIN; OXYGEN; VITAMIN;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BLOOD CELL COUNT; CHILD; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYSTIC FIBROSIS; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; INFANT; IRON DEFICIENCY; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; PRESCHOOL CHILD; SCHOOL CHILD; VITAMIN DEFICIENCY; AGE; BLOOD; HOSPITALIZATION; IRON DEFICIENCY ANEMIA; METABOLISM; MIDDLE AGED; MORTALITY; NUTRITIONAL STATUS; PHYSIOLOGY; RISK FACTOR;

ADOLESCENT; ADULT; AGE FACTORS; ANEMIA; ANEMIA, IRON-DEFICIENCY; AVITAMINOSIS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY FLOW RATES; HEMOGLOBINS; HUMANS; INFANT; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OXYGEN; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VITAMINS;

EID: 55949089961     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0884533608323426     Document Type: Article

References (55)

1. Riordan JR, Rommens JM, Kerem B., et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989 ; 245: 1066-1072.
2. Kerem B., Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989 ; 245: 1073-1080. (Pubitemid 19231815)
3. Boucher RC An overview of the pathogenesis of cystic fibrosis lung disease. Adv Drug Deliv Rev. 2002 ; 54: 1359-1371.
4. Knowles MR, Boucher RC Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest. 2002 ; 109: 571-577.
5. Jayaraman S., Joo NS, Reitz B., Wine JJ, Verkman AS Submucosal gland secretions in airways from cystic fibrosis patients have normal [Na(+)] and pH but elevated viscosity. Proc Natl Acad Sci U S A. 2001 ; 98: 8119-8123.
6. Emerson J., Rosenfeld M., McNamara S., Ramsay B., Gibson RL Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2003 ; 35: 257-262.
7. Nixon GM, Armstrong DS, Carzino R., et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr. 2001 ; 138: 699-704.
8. Dodge JA, Lewis PA, Stanton M., Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J. 2007 ; 29: 522-526.
9. Pond MN, Morton AM, Conway SP Functional iron deficiency in adults with cystic fibrosis. Respir Med. 1996 ; 90: 409-413.
10. Ater JL, Herbst JJ, Landaw, O. ' Brian AT Relative anemia and iron deficiency in cystic fibrosis. Pediatrics. 1983 ; 71: 810-814.
11. Erhardt P., Miller MG Iron deficiency in cystic fibrosis. Arch Dis Child. 1987 ; 62: 185-187.
12. von Drygalski A., Biller J. Anemia in cystic fibrosis (CF): prevalence, mechanisms and correlation with pulmonary function (ASH Annual Meeting Abstract). Blood. 2006 ; 108: 1286.
13. von Drygalski A., Biller J. Anemia is a serious comorbid condition in cytsic fibrosis and is associated with poor lung function [abstract]. Pediatr Pulmonol. 2007 ; 42, Abstract 491.
14. Vichinsky EP, Pennathur-Das R., Nickerson B., et al. Inadequate erythroid response to hypoxia in cystic fibrosis. J Pediatr. 1984 ; 105: 15-21.
15. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease. Am J Kidney Dis. 1996 ; 28: 53-61.
16. Locatelli F., Conte F., Marcelli D. The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity-the experience of the Lombardy Dialysis Registry. Nephrol Dial Transplant. 1998 ; 13: 1642-1644.
17. Besarab A., Bolton WK, Browne JK, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998 ; 339: 584-590.
18. Ma JZ, Ebben J., Xia H., Collins AJ Hematocrit level and associated mortality in hemodialysis patents. J Am Soc Nephrol. 1999 ; 10: 610-619.
19. Knight K., Wade S., Balducci L. Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med. 2004 ; 116 (suppl 7A). 11S - 26S.
20. Wilson A., Yu HT, Goodnough LT, Nissenson AR Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. Am J Med. 2004 ; 116 (suppl 7A). 50S - 57S.
21. Chambellan A., Chailleux E., Similowski T. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest. 2005 ; 128: 1201-1208.
22. Similowski T., Agusti A., Macnee W., Schonhofer B. The potential impact of anaemia of chronic disease in COPD. Eur Respir J. 2006 ; 27: 390-396.
23. Canon JL, Vansteenkiste J., Bodoky G., et al. Randomized, double-blind, active-controlled trial of every-3-week darbepoetin alfa for the treatment of chemotherapy-induced anemia. J Natl Cancer Inst. 2006 ; 98: 273-284.
24. Eschbach JW, Abdulhadi MH, Browne JK, et al. Recombinant human erythropoietin (rHuEPO) in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med. 1989 ; 111: 992-1000.
25. Ross SD, Fahrbach K., Frame D., Scheye R., Connelly JE, Glaspy J. The effect of anemia treatment on selected health-related quality-of-life domains: a systematic review. Clin Ther. 2003 ; 25: 1786-1805.
26. Jones M., Ibels L., Schenkel B., Zagari M. Impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysis. Kidney Int. 2004 ; 65: 757-767.
27. Nicolas G., Chauvet C., Viatte L., et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002 ; 110: 1037-1044.
28. Reid DW, Withers NJ, Francis L., Wilson JW, Kotsimbos TC Iron deficiency in cystic fibrosis. Relationship to lung disease severity and chronic Pseudomonas aeruginosa infection. Chest. 2002 ; 121: 48-54.
29. Zempsky WT, Rosenstein BJ, Carroll JA, Oski FA Effect of pancreatic enzyme supplements on iron absorption. Am J Dis Child. 1989 ; 143: 969-972.
30. Cucchiara S., Santamaria F., Andreotti MR, et al. Mechanisms of gastro-oesophageal reflux in cystic fibrosis. Arch Dis Child. 991 ; 66: 617-622.
31. O'Connor TM, McGrath DS, Short C., O'Donnell MJ, Sheehy M., Bredin CP Subclinical anaemia of chronic disease in adult patients with cystic fibrosis. J Cyst Fibros. 2002 ; 1: 31-34.
32. Fischer R., Simmerlein R., Huber RM, Schiffl H., Lang SM Lung disease severity, chronic inflammation, iron deficiency, and erythropoietin response in adults with cystic fibrosis. Pediatr Pulmonol. 2007 ; 42: 1193-1197.
33. Costa M., Potvin S., Berthiaume Y., et al. Diabetes: a major co-morbidity of cystic fibrosis. Diabetes Metab. 2005 ; 31: 221-232.
34. Konstan MW, Butler SM, Wohl ME, et al. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr. 2003 ; 142: 624-630.
35. Mayer-Hamblett N., Rosenfeld M., Emerson J., Goss CG, Aitken ML Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Resp Crit Care Med. 2002 ; 166: 1550-1555.
36. Weiss G., Goodnough LT Anemia of chronic disease. N Engl J Med. 2005 ; 352: 1011-1023.
37. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995 ; 152: 1107-1136.
38. Cystic Fibrosis Foundation. Patient Registry 2004 Annual Report. Bethesda, MD: Cystic Fibrosis Foundation.
39. Cystic Fibrosis Foundation. Patient Registry 1994 Annual Report. Bethesda, MD: Cystic Fibrosis Foundation.
40. Davis PB Cystic fibrosis since 1938. Centennial review. Am J Respir Crit Care Med. 2006 ; 173: 475-482.
41. Accurso FJ Update in cystic fibrosis 2005. Am J Respir Crit Care Med. 2006 ; 173: 944-947.
42. DeMaeyer E., Adiels-Tegman M. The prevalence of anaemia in the world. World Health Stat Q. 1985 ; 38: 302-316.
43. Thurlow RA, Winichagoon P., Green T., et al. Only a small proportion of anemia in northeast Thai schoolchildren is associated with iron deficiency. Am J Clin Nutr. 2005 ; 82: 380-387.
44. Calis JC, Phiri KS, Faragher EB, et al. Severe anemia in Malawian children. N Engl J Med. 2008 ; 358: 888-899.
45. Evans T. Regulation of hematopoiesis by retinoid signalling. Exp Hematol. 2005 ; 33: 105-161.
46. Jain SK, Levine SN, Duett J., Hollier B. Reduced vitamin E and increased lipofuscin products in erythrocytes of diabetic rats. Diabetes. 1991 ; 40: 1241-1244.
47. Usberti M., Gerardi G., Bufano G., et al. Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients. Am J Kidney Dis. 2002 ; 40: 590-599.
48. Zimmermann MB, Biebinger R., Rohner F., et al. Vitamin A supplementation in children with poor vitamin A and iron status increases erythropoietin and hemoglobin concentrations without changing total body iron. Am J Clin Nutr. 2006 ; 84: 580-586.
49. Fawzi WW, Msamanga GI, Kupka R., et al. Multivitamin supplementation improves hematologic status in HIV-infected women and their children in Tanzania. Am J Clin Nutr. 2007 ; 85: 1335-1343.
50. Jilani T., Moiz B., Iqbal MP Vitamin E supplementation enhances hemoglobin and erythropoietin levels in mildly anemic adults. Acta Haematol. 2008 ; 119: 45-47.
51. Fishman SM, Christian P., West KP Jr. The role of vitamins in the prevention and control of anaemia. Public Health Nutr. 1999 ; 3: 125-150.
52. Garca-Casal MN, Layrisse M., Solano L., et al. Vitamin A and betacarotene can improve nonheme iron absorption from rice, wheat and corn by humans. J Nutr. 1998 ; 128: 646-650.
53. Finch CA, Miller LR, Inamdar AR, et al. Iron deficiency in the rat. Physiological and biochemical studies of muscle dysfunction. J Clin Invest. 1976 ; 58: 447-453.
54. Keevil B., Rowlands D., Burton I., et al. Assessment of iron status in cystic fibrosis patients. Ann Clin Biochem. 2000 ; 37: 662-665.
55. Huebers HA, Beguin Y., Pootrakul P., et al. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood. 1990 ; 75: 102-107.